ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978

Breast Density As Important As Age In Determining Risk

September 29, 2006

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought

September 12, 1975

Comprehensive Center NCAB Evaluations

June 2, 1978

AACI Asks NCI for Better Definitions Of Center Types, Development Of Objectives, Priorities

June 25, 1976